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INTRODUCTION
Astroblastoma is a rare glial tumor occurring predominantly
in the cerebral hemispheres of young adults. There have been
numerous questions about the histogenesis of the astroblas-
toma (1). It is difficult to determine exact number of astrob-
lastoma cases since the number may include some that are
not typical astroblastoma. However in some report it was esti-
mated that only 0.45-2.8% of all neuroglial tumors were as-
troblastoma (2). Domestically, no such cases have been report-
ed so far. Astroblastomas are well demarcated and show char-
acteristic perivascular pseudorosettes. Similar perivascular
pseudorosettes may also occur partly in gemistocytic astro-
cytoma, anaplastic oligodendroglioma, anaplastic astrocytoma,
glioblastoma, etc. Therefore, the term, astroblastoma, must
be used only for the cases in which typical histological find-
ings are observed throughout the tumor (3).
CASE REPORT
A 15-yr-old female patient had presented with headache
and diplopia for one year and six months, and her headache
in the area of right frontal lobe had become worse for the last
month. The neurological examination showed diplopia, right
nasal hemianopia, and papillary edema. Brain MRI showed
a well demarcated mass, 9.7 cm in diameter, in right frontal
lobe. After an injection of gadolinium, the tumor showed an
inhomogenous enhancement. Within the tumor there were
many cystic changes of different sizes (Fig. 1). It was com-
pletely removed surgically.
Histologically, perivascular pseudorosettes were observed
throughout the tumor. In perivascular pseudorosettes, tumor
cells were aligned along the fibrovascular stalk by one or two
cell layers, but in some areas it was multilayered. Perivascu-
lar pseudorosettes became prominent in areas where the tumor
cells were separated by artifacts (Fig. 2). Tumor cells forming
perivascular pseudorosettes extended eosinophilic cytoplasmic
processes toward vessel wall. Cytoplasmic processes were short
and thick, of which blunt footplates were attached to the ves-
sels (Fig. 3). Most tumor cells showed nuclear monotony with
less atypism, yet a small number of them showed mild nuclear
atypia. Multinucleated cells were occasionally observed in
the areas with atypical nuclei. The tumor cell nuclei showed
coarse chromatin pattern and no prominent nucleoli. Mitotic
figures were rarely observed. Blood vessels were mostly of
capillaries without smooth muscle layers. There was no glial
fibrillarity in the fibrovascular stalk. The macrophages were
frequently infiltrated in fibrovascular stalks. Vascular hyalin-
ization or sclerosis was observed in some areas, but no endo-
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Astroblastoma
: A Case Report
Astroblastoma is one of the very unusual type of tumors, whose histogenesis has
not been clarified. It occurs mainly among children or young adults. Astroblastoma
is grossly well-demarcated, and shows histologically characteristic perivascular pseudo-
rosettes with frequent vascular hyalinization. Perivascular pseudorosettes in astroblas-
toma have short and thick cytoplasmic processes and blunt-ended foot plates. A
15-yr-old girl presented with headache and diplopia for one and a half year. A well-
demarcated mass, 9.7 cm in diameter, was found in the right frontal lobe in brain MRI,
and it was a well-enhanced inhomogenous mass. Cystic changes of various sizes
were observed inside the tumor mass as well as in the posterior part of the mass,
but no peritumoral edema was found. Histologically, this mass belongs to a typical
astroblastoma, and no sign of anaplastic astrocytoma, gemistocytic astrocytoma or
glioblastoma was found in any part of the tumor. Immunohistochemically, the tumor
cells showed diffuse strong positivity for glial fibrillary acidic protein, S-100 protein,
vimentin and neuron specific enolase, and focal positivity for epithelial membrane
antigen and CAM 5.2, while showing negativity for synaptophysin, neurofilament
protein, pan-cytokeratin and high molecular weight keratin.
Key Words : Brain Neoplasms; Neoplasms, Neuroepithelial; Astroblastoma; Immunohistochemistry; Diagno-
sis, Differential
Received : 23 June 2003
Accepted : 26 September 2003Astroblastoma 773
thelial proliferation was found (Fig. 4). Focal tumor necrosis
was present. Areas of anaplastic astrocytoma, gemistocytic
astrocytoma, and glioblastoma were not found in any part
of the tumor. 
Cytoplasmic processes of tumor cells composing perivas-
cular pseudorosettes showed strong positive reaction for glial
fibrillary acidic protein (GFAP) (Fig. 5). Tumor cells in dis-
cohesive areas showed GFAP-positive short cytoplasmic pro-
cesses. The tumor cells showed diffuse strong positivity for
S-100 protein, vimentin and neuron specific enolase (NSE),
and focal positivity for epithelial membrane antigen (EMA)
and CAM 5.2 (Fig. 6). The tumor cells were negative for
synaptophysin, neurofilament protein (NFP), pan-cytokeratin,
high molecular weight keratin (HMWK) immunostains.
MIB-1 labeling index accounted for 8.0% (83/1,000), and
p53 positivity was 16% (159/1,000) (Table 1).
Six weeks after the operation, radiation therapy of 4,500 cGy
was performed for a period of seven weeks. Three years and
nine months after the operation visual acuity decreased slowly
and the left hemiplegia developed progressively. Multiple low
intensity lesions was observed in T1-weighted image, and
they were considered as radionecrosis. Four years after the
operation the patient died of brain stem failure.
DISCUSSION
Since Bailey and Bucy reported on astroblastoma for the
first time in 1930, the existence of the tumor itself has been
Fig. 1. (A) T1-weighted image shows a huge well-demarcated mass in the right frontal lobe. (B) Many cystic changes of different sizes
are observed within the tumor on T2-weighted image. (C) The tumor shows an inhomogenous enhancement.
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Fig. 2. Well-developed perivascular pseudorosettes are seen th-
roughout the tumor (H&E, ×40).
Fig. 3. The tumor cells composing perivascular pseudorosettes
display short and thick cytoplasmic processes with prominent
blunt-ended footplates toward the vessel wall (H&E, ×400).774 D.S. Kim, S.Y. Park, S.P. Lee
one of the most interesting subjects (4). However, from the
middle of the 1980s up until today, astroblastoma has been
reported as a distinct entity (1, 5-9). Astroblastoma occur most
frequently in young adults, occasionally in children. Congeni-
tal astroblastoma rarely occurred (2). Approximately 40 cases
were reported in the literatures so far. The patients ranged
from 1 to 58 yr old (average, 16 yr) (1, 8, 9). There seems to
be no significant differences between genders (10, 11). Astro-
blastoma develops usually in cerebral hemisphere, but it can
develop in the corpus callosum, cerebellum, optic nerve, brain
stem, or in filum terminale (7, 11). In cerebral hemispheres,
astroblastoma usually develops in cortex, subcortical area, and
periventricular area, but not in the ventricle itself (11).
Astroblastoma is a well-demarcated tumor with variable
sized cystic changes. Histologically, astroblastoma has char-
acteristic perivascular pseudorosettes. Different from the peri-
vascular pseudorosettes in ependymoma, those in astroblas-
toma have short and thick cytoplasmic processes. The cyto-
plasmic processes have blunt-ended footplates and are attached
to basal lamina of blood vessels. In less cellular areas, perivas-
Fig. 4. The fibrovascular stroma frequently shows prominent vas-
cular sclerosis (H&E, ×40).
Fig. 5. The broad GFAP-positive glial processes surround blood
vessels (×400).
Fig. 6. The tumor cells are positive for S-100 protein (A), vimentin (B), and CAM 5.2 (C) (×200).
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cular pseudorosettes look more distinct. Typical perivascular
pseudorosettes are observed even in the areas where tumor
cells show solid growth patterns. Most of tumor cells have
monotonous nuclei with coarse chromatin pattern. The blood
vessels frequently show hyalinization and even sclerosis (1, 3,
8, 10, 11). This case showed all of these histological findings.
Astroblastomas are classified into low grade and high grade
according to histological findings (8). The high grade astrob-
lastomas show increased cellularity with multiple cell layers
upon the vascular walls. Tumor cells have severe nuclear atypia
with increased mitotic figures. Vascular endothelial prolifer-
ation is also observed without prominent vascular hyaliniza-
tion (8, 9). Overall histological findings in this case were com-
patible with the low grade astroblastoma.
Immunohistochemically, the tumor cells showed positivity
for GFAP, S-100 protein, vimentin, NSE and EMA coincid-
ing with the findings in other reports (2, 6, 12-14). The fact
that neoplastic astrocytes may be positive for NSE and EMA
is well known (12). However, reactions to CAM 5.2 reported
as negative (2, 11, 12) or partly positive (13). This case showed
positivity for CAM 5.2. Reason for the difference would be
due to difference in antibodies used.
The term ‘astroblastoma’ is misleading in itself, since this
tumor is not overtly astrocytic, nor are they ‘blastic’ (1). Bailey
and Bucy believed that astroblastoma originated from astro-
blast, an intermediate stage between glioblasts and astrocytes
(4). However, in a study by means of electron microscope it
was proved that tumor cells of astroblastoma are intermediate
between astrocytes and ependymal cells, and thus a possibil-
ity of tanycytes is presented as the origin of astroblastoma (7,
13, 15).
Tumors showing histological findings similar to astroblas-
toma are ependymoma, papillary meningioma, choroid plexus
tumor, etc. Ependymoma is usually a well-demarcated mass
and forms perivascular pseudorosettes, which may be confused
with astroblastoma. It also shows positivity for GFAP, S-100
protein and vimentin and even focal positivity for cytokeratin,
as astroblastoma does. However, perivascular pseudorosettes
in ependymoma have thin and long cytoplasmic processes
with no foot plates, which are different from the pseudorosettes
of astroblastoma. And anuclear fibrillary zone is well devel-
oped around the blood vessels. Tumor cells between perivas-
cular pseudorosettes are compact and show small ovoid mono-
tonous nuclei with fine chromatin pattern. Papillary menin-
gioma has perivascular papillary or pesudopapillary pattern
with structures similar to pseudorosettes of ependymoma. The
tumor cells of papillary meningioma show positive reaction
for cytokeratin and negative reaction for GFAP. In addition,
papillary meningiomas usually show connection to meninges
as well as typical meningioma areas. Choroid plexus tumor
also shows papillary growth pattern, which may be confused
with astroblastoma. However, most of choroid plexus tumor
develops within ventricle. Immunohistochemically choroid
plexus tumor shows strong positivity for cytokeratin, while
negativity or focal positivity for GFAP, and characteristic
transthyretin positivity (16, 17).
The natural history of the astroblastoma seems to place it
between the astrocytoma and glioblastoma (8). The low-grade
astroblastomas are thought to have better prognosis than the
high-grade astroblastomas. Gross total resection may result
in long-term survival. Anaplastic histology has been associ-
ated with recurrence and progression, suggesting the more
aggressive treatment, including radiotherapy, is necessary for
high-grade lesions (1, 8, 9, 16).
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